Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Lymphomes non hodgkinien
- | Specialty :
- Chimiothérapie
Extract
A phase I open-label dose-escalation study of intravenous aflibercept (AVE0005, VEGF trap) in combination with r-chop administered every 2 weeks or every 3 weeks in patients with non hodgkin's B-cell lymphoma.
Scientific Abstract
en cours d'intégration;